Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Ziyuglycoside II is a steroid glycoside that has been found in S. officinalis and has diverse biological activities.1,2,3 It is cytotoxic to SMMC-7721, PC-9, HCT116, MCF-7, and MDA-MB-231 cancer cells when used at concentrations of 30 and 90 µg/ml.1 Ziyuglycoside II (6, 12, and 18 mg/kg) increases the number of white blood cells in peripheral blood and the number of hematopoietic stem and progenitor cells (HSPCs) in a mouse model of leukopenia induced by the nitrogen mustard alkylating agent cyclophosphamide (Item No. 13849).2 It also reduces small intestinal epithelial cell apoptosis and IL-1β, IL-6, and TNF-α levels, as well as improves diarrhea symptoms in a mouse model of rotavirus-induced diarrhea.3
WARNING This product is not for human or veterinary use.
1. Ziyuglycoside II exerts antiproliferative and antimetastasis effects on hepatocellular carcinoma cells. Anticancer Drugs 31(8), 819-827 (2020).
2. Ziyuglycoside II alleviates cyclophosphamide-
3. Ziyuglycoside II inhibits rotavirus induced diarrhea possibly via TLR4/NF-